UBS Group (SWX:UBSG) Could Be 49% Below Fair Value After Asia Banking Hire

UBS Group (SWX:UBSG) is back in focus after UBS AG appointed Samuel Thong as head of Asia healthcare investment banking, excluding Japan. The move aims to expand the bank’s advisory reach in that sector.

UBS Group’s latest leadership move in Asia comes as momentum in the stock has been strong, with a 90 day share price return of 20.22% and a year to date share price return of 16.66%. The 1 year total shareholder return of 41.07% points to solid recent investor gains.

Scan other banks riding similar dealmaking momentum by reviewing the hand picked 262 high quality undervalued stocks that combine recent strength with established balance sheet and cash flow quality.

UBS Group now trades close to analyst targets yet sits at a sizable discount to one estimate of intrinsic value. After this run and the new Asia investment banking hire, is the market still too cautious or already fair?

Most Popular Narrative: 1% Overvalued

UBS Group closed at CHF44.53 compared with a widely followed fair value narrative of CHF44.11, which keeps the debate finely balanced around upside from here.

The ongoing integration of Credit Suisse is progressing ahead of schedule, driving meaningful cost savings, increased scale, and improved operating efficiency. As these synergies are realized through further platform migration and operational streamlining, UBS's net margins and return on equity are likely to improve, supporting higher earnings growth.

Read the complete narrative. Read the complete narrative.

Analysts are leaning on a mix of modest revenue expansion, higher profit margins, and a future earnings multiple that differs from today. Curious which of these levers really drives the fair value story for UBS Group.

Result: Fair Value of CHF44.11 (OVERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, UBS Group still faces meaningful execution and compliance risks, particularly around the Credit Suisse integration and the recent US$125m anti money laundering settlement and remediation plan.

Find out about the key risks to this UBS Group narrative.

Another View On UBS Group’s Valuation

The analyst narrative suggests UBS Group is only around 1% overvalued at CHF44.53 against a fair value of CHF44.11. Our DCF model points to something different. It estimates a future cash flow value of CHF66.55, which implies the current price is trading at a sizeable discount.

This gap between a near fully priced analyst target and an SWS DCF model that flags upside raises a simple question for investors: Are analyst earnings and risk assumptions cautious, or is the DCF leaning too hard on long term cash flow power?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out UBS Group for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 262 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

Does the mixed message around UBS Group’s valuation leave you curious about the real balance of risk and reward? Take a closer look at the 3 key rewards and 4 important warning signs.

Looking for more investment ideas beyond UBS Group?

If UBS Group has your attention, do not stop here. Use the Simply Wall Street Screener to quickly spot focused opportunities across different styles and risk profiles.

• Target potential income strength by reviewing companies highlighted in the 416 dividend fortresses that may appeal to dividend focused investors.
• Hunt for resilient businesses through the 308 resilient stocks with low risk scores that prioritise balance sheet durability and lower overall risk scores.
• Seek future standouts before the crowd by checking the 613 high quality undiscovered gems that combine financial quality with limited current attention.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com